RIFADIN 150 RIFADIN 150 Pill - red capsule/oblong, 14mm
Generic Name: rifampin
Pill with imprint RIFADIN 150 RIFADIN 150 is Red, Capsule/Oblong and has been identified as Rifadin 150 mg. It is supplied by Aventis Pharmaceuticals.
Rifadin is used in the treatment of Bartonellosis; Endocarditis; Legionella Pneumonia; Haemophilus influenzae Prophylaxis; Leprosy and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy. Rifadin 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RIFADIN 150 RIFADIN 150
Rifadin
- Generic Name
- rifampin
- Imprint
- RIFADIN 150 RIFADIN 150
- Strength
- 150 mg
- Color
- Red
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Rifamycin derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aventis Pharmaceuticals
- Inactive Ingredients
-
corn starch,
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Red No. 40,
magnesium stearate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00068-0510 (Discontinued) | Upsher-Smith Laboratories Inc. |
| 52959-0461 (Discontinued) | H.J. Harkins Company, Inc. (repackager) |
More about Rifadin (rifampin)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: rifamycin derivatives
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
